Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Study Links Depression to Alzheimer's Disease

Ivanhoe Broadcast News


Related Encyclopedia
 border=
Alzheimer's Disease
Dementia
Ginkgo Biloba
Hip Replacement
More...

Related Healthscout Videos
 border=
Custom Ankle Replacements
Shutting Down Tremor.
Disaster Heart Attacks
Teaching Old Docs New Tricks
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Erectile Dysfunction
What is a Heart Attack?
More...

Related Drug Information
 border=
Actonel
Coumadin
Detrol LA
Ditropan XL
More...

Related News Articles
 border=
All Ages at Risk for H1N1 Complications
Diabetes Slows Alzheimer's Memory Loss?
Vision Troubles may Signal Alzheimer's
Study: Preserving Heart Function Prevents Aging
More...

(Ivanhoe Newswire) -- Research shows that the popular Alzheimer's drug Donepezil may delay the progression to Alzheimer's disease in depressed people with Mild Cognitive Impairment (MCI). MCI is described as that period between normal aging and Alzheimer's.

For three years, researchers followed 756 people aged 55 to 91 with MCI. Of those, 208 were diagnosed with depression. Researchers used a test to measure severity of depressive symptoms. For every one point increase on the test, the participant's risk of developing Alzheimer's rose 3 percent. "Our longer term findings add to the body of evidence that suggests depression is a major risk factor for Alzheimer's disease," study author Po H. Lu, of the David Geffen School of Medicine at UCLA was quoted as saying.

Text Continues Below



Study participants were given vitamin E, Donepezil or a placebo. Though Donepezil had little effect on those who were not depressed, among those diagnosed with depression, the percentage receiving vitamin E or placebo who developed Alzheimer's was double that of those receiving Donezepil.

Donepezil is not FDA approved for use in patients with MCI, but is indicated only for patients diagnosed with Alzheimer's.

"If we can delay the progression of this disease for even two years," said Lu, "it could significantly improve the quality of life for many people dealing with memory loss."

Source: Neurology, June 16, 2009



If this story or any other Ivanhoe story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Melissa Medalie at mmedalie@ivanhoe.com

This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/.




Last updated 6/16/2009

Related Links
 border=
From Healthscout's partner site on alzheimer's disease, OurAlzheimers.com
I need to know about Alzheimer's symptoms.
What are the stages of Alzheimer's Disease?
Learn about Alzheimer's medications.






About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy